<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="436">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05155475</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A03461-54</org_study_id>
    <nct_id>NCT05155475</nct_id>
  </id_info>
  <brief_title>Endoscopic Ultrasound Evaluation of the Common Bile Duct in Patients With Obstructive Jaundice Due to Bilio-pancreatic Malignancies (ECCO Trial)</brief_title>
  <acronym>ECCO</acronym>
  <official_title>Endoscopic Ultrasound Evaluation of the Common Bile Duct in Patients With Obstructive Jaundice Due to Bilio-pancreatic Malignancies: a Multicenter Prospective Study (ECCO Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramsay Générale de Santé</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Clinical Trial Experts Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ramsay Générale de Santé</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the size of the common bile duct in a large cohort of patients with jaundice&#xD;
      following a malignant tumor of the head of the pancreas or the distal bile duct receiving a&#xD;
      diagnostic EA for biopsy and / or for evaluation of tissue resectability.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 4, 2019</start_date>
  <completion_date type="Actual">December 18, 2019</completion_date>
  <primary_completion_date type="Actual">December 4, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the common bile duct size</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>Obstructive Jaundice</condition>
  <condition>Bilio-pancreatic Tumor</condition>
  <arm_group>
    <arm_group_label>Patient with jaundice</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound endoscopy</intervention_name>
    <description>After identification of the lesion, the common bile duct will be identified and followed by the point of dilation due to the compression of the known lesion up to the hilum of the liver</description>
    <arm_group_label>Patient with jaundice</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients over 18 years old, with jaundice&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with jaundice and an injury to the head of the pancreas recommended for&#xD;
             EUS-guided tissue acquisition or staging&#xD;
&#xD;
          -  Patients with jaundice and distal CBD lesion suggestive of cholangiocarcinoma or&#xD;
             Vater's ampulla carcinoma recommended for EUS-guided tissue acquisition or staging&#xD;
&#xD;
          -  Serum bilirubin level ≥ 3 mg / dl&#xD;
&#xD;
          -  Age ≥ 18 years old&#xD;
&#xD;
          -  Subject affiliated or beneficiary of a social security scheme.&#xD;
&#xD;
          -  Subject having been informed of this study and having given his no objection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of altered anatomy due to previous gastric surgery (Billroth II or Roux-en-Y&#xD;
             anastomosis)&#xD;
&#xD;
          -  Sphincterotomy performed previously, plastic biliary stent or metal stent placement&#xD;
&#xD;
          -  Percutaneous drainage of the bile ducts performed previously&#xD;
&#xD;
          -  Pregnant, breastfeeding or parturient woman&#xD;
&#xD;
          -  Protected patients: Adults under guardianship, curatorship or other legal protection,&#xD;
             deprived of their liberty by judicial or administrative decision; hospitalized without&#xD;
             consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hôpital Jean Mermoz</name>
      <address>
        <city>Lyon</city>
        <zip>69008 Lyon</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 30, 2021</study_first_submitted>
  <study_first_submitted_qc>November 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2021</study_first_posted>
  <last_update_submitted>November 30, 2021</last_update_submitted>
  <last_update_submitted_qc>November 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
    <mesh_term>Jaundice</mesh_term>
    <mesh_term>Jaundice, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

